Geneva Partners’s iShares Russell 2000 ETF IWM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$448K Sell
1,806
-73
-4% -$18.8K 0.22% 52
2025
Q4
$462K Buy
1,879
+1
+0.1% +$246 0.16% 56
2025
Q3
$454K Buy
1,878
+1
+0.1% +$229 0.17% 58
2025
Q2
$405K Sell
1,877
-2,756
-59% -$555K 0.16% 62
2025
Q1
$924K Sell
4,633
-876
-16% -$190K 0.48% 40
2024
Q4
$1.22M Sell
5,509
-140
-2% -$31.9K 0.49% 39
2024
Q3
$1.25M Buy
5,649
+369
+7% +$79K 0.54% 42
2024
Q2
$1.07M Buy
5,280
+2,490
+89% +$503K 0.44% 47
2024
Q1
$587K Sell
2,790
-384
-12% -$76.6K 0.26% 55
2023
Q4
$637K Buy
+3,174
New +$569K 0.35% 52
2022
Q1
Sell
-2,466
Closed -$549K 99
2021
Q4
$549K Sell
2,466
-1,935
-44% -$437K 0.26% 65
2021
Q3
$963K Buy
4,401
+403
+10% +$89.3K 0.46% 47
2021
Q2
$917K Buy
3,998
+303
+8% +$68.1K 0.42% 53
2021
Q1
$816K Buy
3,695
+433
+13% +$94.5K 0.42% 52
2020
Q4
$640K Buy
+3,262
New +$571K 0.34% 63

Other funds holding IWM

Geneva Partners's IWM Position: Q1 2026 in Review

Geneva Partners reduced its iShares Russell 2000 ETF (IWM) stake by 3.9% in Q1 2026, selling an estimated $18.8K and leaving 1,806 shares worth $448K. The position accounts for 0.22% of the portfolio, ranked #52.

Geneva Partners first reported a position in IWM in Q4 2020 and has held it in 15 quarters since. The position peaked at $1.25M in Q3 2024. 2,568 funds tracked by Wall St. Rank hold IWM as of Q1 2026.

  • Geneva Partners held 1,806 shares of iShares Russell 2000 ETF worth $448K as of Q1 2026.
  • Geneva Partners sold 73 iShares Russell 2000 ETF shares in Q1 2026, an estimated $18.8K.
  • iShares Russell 2000 ETF made up 0.22% of Geneva Partners's portfolio in Q1 2026, its #52 holding.
  • Geneva Partners first reported a position in iShares Russell 2000 ETF in Q4 2020 and has held it in 15 quarters since.
  • Geneva Partners's iShares Russell 2000 ETF position peaked at $1.25M in Q3 2024.
  • 2,568 funds tracked by Wall St. Rank held iShares Russell 2000 ETF as of Q1 2026.

Based on Geneva Partners's 13F filing for Q1 2026, filed 29 Apr 2026.